4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-020571
President and CEO sold 5,225 shares at an average $0.36 ($1,906)
- President and CEO acquired 18,182 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucchino David L. · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-07 | Sale : show line 1 in the form 10b5-1 | −2,634 | $0.35 | $922 | 436,196 | D |
| 2023-07-07 | Exercise or conversion : show line 2 in the form 10b5-1 | +9,091 | 445,287 | D | ||
| 2023-07-10 | Sale : show line 3 in the form 10b5-1 | −2,591 | $0.38 | $985 | 442,696 | D |
| 2023-07-10 | Exercise or conversion : show line 4 in the form 10b5-1 | +9,091 | 451,787 | D | ||
| Open-market sales · 5,225 sh · avg $0.36 · $1,906 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2023-07-07 | Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Unit | −9,091 | 9,091 | 272,727 | D |
| 2023-07-10 | Exercise or conversion : show line 6 in the form 10b5-1 Restricted Stock Unit | −9,091 | 9,091 | 263,636 | D |
Loading xslF345X04/form4.xml…